1 Answer
Ranbaxy, an India-based pharmaceutical company, agreed to delay release of its generic version of Lipitor until Nov. 30.
According to its website, Ranbaxy will have the exclusive right to sell its drug in the U.S. for six months.
Experts say when generic versions of these drugs make it to market, pharmaceutical companies could face billions in potential losses, while consumers could save tens of billions of dollars a year.
13 years ago. Rating: 0 | |
Top contributors in Uncategorized category
Unanswered Questions
8XBET
Answers: 0
Views: 3
Rating: 0
keonhacai4comco
Answers: 0
Views: 7
Rating: 0
Cao Minh Tuyên
Answers: 0
Views: 5
Rating: 0
Vb9 - Link nhà cái Vb9 trang chủ chính thức, không bị chặn
Answers: 0
Views: 7
Rating: 0
goal123red
Answers: 0
Views: 8
Rating: 0
8kbettguru
Answers: 0
Views: 7
Rating: 0
32winsncom
Answers: 0
Views: 6
Rating: 0
Cao Nghĩa
> More questions...
Answers: 0
Views: 6
Rating: 0